Parsons Capital Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-11,473
Closed -$237K 453
2024
Q2
$237K Sell
11,473
-565
-5% -$11.2K 0.02% 409
2024
Q1
$226K Sell
12,038
-253
-2% -$4.34K 0.02% 412
2023
Q4
$177K Sell
12,291
-1,713
-12% -$23.3K 0.01% 421
2023
Q3
$243K Sell
14,004
-251
-2% -$5.23K 0.02% 381
2023
Q2
$297K Sell
14,255
-1,356
-9% -$29.5K 0.02% 365
2023
Q1
$367K Sell
15,611
-206
-1% -$5.53K 0.03% 334
2022
Q4
$442K Sell
15,817
-16,061
-50% -$411K 0.04% 300
2022
Q3
$746K Sell
31,878
-5,371
-14% -$162K 0.07% 229
2022
Q2
$1.26M Sell
37,249
-10,526
-22% -$369K 0.11% 173
2022
Q1
$1.67M Sell
47,775
-452
-0.9% -$15.5K 0.13% 153
2021
Q4
$1.47M Sell
48,227
-1,919
-4% -$62.5K 0.11% 177
2021
Q3
$1.64M Buy
50,146
+402
+0.8% +$12.9K 0.13% 158
2021
Q2
$1.5M Buy
+49,744
New +$1.64M 0.12% 169

Other funds holding OGN

Parsons Capital Management's OGN Position: Q3 2024 in Review

Parsons Capital Management sold out of Organon & Co (OGN) in Q3 2024, closing a stake of 11,473 shares — an estimated $237K sold.

Parsons Capital Management first reported a position in OGN in Q2 2021 and held it in 13 quarters. The position peaked at $1.67M in Q1 2022. 724 funds tracked by Wall St. Rank hold OGN as of Q3 2024.

  • Parsons Capital Management reported no remaining Organon & Co position as of Q3 2024 after selling out during the quarter.
  • Parsons Capital Management sold 11,473 Organon & Co shares in Q3 2024, an estimated $237K.
  • Parsons Capital Management first reported a position in Organon & Co in Q2 2021 and held it in 13 quarters.
  • Parsons Capital Management's Organon & Co position peaked at $1.67M in Q1 2022.
  • 724 funds tracked by Wall St. Rank held Organon & Co as of Q3 2024.

Based on Parsons Capital Management's 13F filing for Q3 2024, filed 4 Nov 2024.